Literature DB >> 10648651

Post-transcriptional regulation of mouse kappa-opioid receptor expression.

L N Wei1, X Hu, J Bi, H Loh.   

Abstract

Three mRNA variants are generated from the mouse kappa-opioid receptor (KOR) gene. The expression patterns of these KOR mRNA variants in adult animal tissues and during developmental stages are examined. Furthermore, the biological significance of generating these variants is demonstrated with respect to two post-transcriptional mechanisms, i.e., mRNA stability and translation efficiency. Variants A and B are both transcribed from promoter 1 of the KOR gene and expressed from early developmental stages through adult life. Although their sequences differ only at a 30-nucleotide insertion for variant B, these two variants are distinct with regard to their expression patterns, mRNA stability, and translation efficiency. Variant A is expressed ubiquitously in all the tissues examined and has a longer t(1/2) (12 h), whereas variant B is more specific to the central nervous system both pre- and postnatally and has a t(1/2) of approximately 8 h. Variant C is transcribed from promoter 2 of the KOR gene and is most specifically expressed, being detected only in the brain stem, spinal cord, and thalamic/hypothalamic areas of postnatal animals. With regard to protein translation, variants B and C are significantly more efficient than variant A. This study provides the evidence for multiple levels of KOR regulation. The biological implication of the generation of KOR mRNA variants is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648651

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  17 in total

Review 1.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 3.  Transcriptional and epigenetic regulation of opioid receptor genes: present and future.

Authors:  Li-Na Wei; Horace H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

4.  Copb1-facilitated axonal transport and translation of kappa opioid-receptor mRNA.

Authors:  Jing Bi; Nien-Pei Tsai; Hsin-Yi Lu; Horace H Loh; Li-Na Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-13       Impact factor: 11.205

Review 5.  Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach.

Authors:  Michael A Emery; Huda Akil
Journal:  Annu Rev Neurosci       Date:  2020-02-28       Impact factor: 12.449

6.  Stress-induced epigenetic regulation of κ-opioid receptor gene involves transcription factor c-Myc.

Authors:  Shlomit Flaisher-Grinberg; Shawna D Persaud; Horace H Loh; Li-Na Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

Review 7.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

8.  Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.

Authors:  S K Buch; V K Khurdayan; S E Lutz; P E Knapp; N El-Hage; K F Hauser
Journal:  Neuroscience       Date:  2007-05-02       Impact factor: 3.590

9.  Epigenetic regulation of kappa opioid receptor gene in neuronal differentiation.

Authors:  S W Park; Y He; S G Ha; H H Loh; L-N Wei
Journal:  Neuroscience       Date:  2008-01-16       Impact factor: 3.590

10.  A novel signaling pathway of nitric oxide on transcriptional regulation of mouse kappa opioid receptor gene.

Authors:  Sung Wook Park; Jinhua Li; Horace H Loh; Li-Na Wei
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.